MiMedx Group, Inc.   Report issue

For profit Phase 3 Phase 4
Founded: Marietta GA United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2016
NCT02844660
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

MiMedx Group, Inc.